Ambarish Pandey, MD
Enriched profileAssociate Professor, Department of Internal Medicine, Division of Cardiology · UT Southwestern Medical Center
Ambarish Pandey is Associate Professor, Department of Internal Medicine, Division of Cardiology at UT Southwestern Medical Center. OpenAlex indexes 647 publications with 35,834 citations (h-index 75); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Ambarish Pandey, MD, is Associate Professor, Department of Internal Medicine, Division of Cardiology at UT Southwestern Medical Center, Dallas, Texas. The public record shows 647 publications with 35,834 citations (h-index 75), centered on Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiovascular and exercise physiology. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 25 companies, 5 NIH-funded awards (2020–2026).
- Most recent indexed publication: 2026 · Nature medicine
- Top research focus: Cardiovascular Function and Risk Factors
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 25 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 72 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 262.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Sponsor: University of Texas Southwestern Medical Center
- Polypill for Prevention of Cardiomyopathy
Sponsor: University of Texas Southwestern Medical Center
- Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 27 Aug 2026
25 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year20258 payments$41,312openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202521 payments$23,913openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year202518 payments$22,326openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
65.1%Loop diuretic20.9%Torsemide51%Furosemide42%Furoscix7%Part D<11 patientsAldosterone antagonist (MRA)14.2%Spironolactone100%Part D≥50 patientsMetabolism & gastrointestinal
34.9%SGLT2 inhibitor16.6%Jardiance85%Farxiga15%Part D<11 patientsGLP-1 receptor agonist13.1%Ozempic70%Mounjaro20%Rybelsus10%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Polypill strategy for the treatment of patients after acute coronary syndromes - A multicenter randomized controlled trial
Ut Southwestern Medical Center
FY2026$668,630R01HL173838 - Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population
Ut Southwestern Medical Center
FY2025$735,237R01MD017529 - Polypill strategy for the treatment of patients after acute coronary syndromes - A multicenter randomized controlled trial
Ut Southwestern Medical Center
FY2025$730,276R01HL173838
Congress activity
Updated 27 Aug 2026
5 congress contributions (2012–2022) across AACR, ADA, ASCO, ASH per OpenAlex. The most recent:
- Clonal Hematopoiesis and Heart Failure with Preserved Ejection Fraction
ASH Annual Meeting
ASH2022Co-author - 221-LB: Effects of Liraglutide on Visceral and Ectopic Fat in Adults with Overweight/Obesity at High Cardiovascular Risk: A Randomized Clinical Trial
ADA Scientific Sessions
ADA2021Co-authorLate-breaking - 144-LB: Medicaid Expansion and Utilization of Antihyperglycemic Therapies
ADA Scientific Sessions
ADA2020Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.
Nature medicine
Article2026 - Toward Phenotype-Stratified Perioperative Cardiac Risk Prediction.
European journal of preventive cardiology
Comment2026 - Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis.
European journal of preventive cardiology
Clinical Trial2026 - Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease.
Diabetes, obesity & metabolism
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Exerkines in health, resilience and disease866 citations2022
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ambarish-pandey-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/ambarish-pandey-17393314
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Ambarish-Pandey-38537375
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/RadcliffeCardiology/videos/%EF%B8%8Fnew-aha25-lbct-interview-dr-ambarish-pandey-joins-to-discuss-findings-from-the-/1770242800341504
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/reel/DQ4dKWfElRV
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Instagram
instagram.com/utswheartandvascular/p/DHoFRqmuVs2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- Board Certified
American Board of Internal Medicine - Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
Editorial & leadership roles
journal and society appointments- Medical Director
Heart Failure with Preserved Ejection Fraction (HFpEF) Program, UT Southwestern
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Principal Investigator
Cardiometabolic Research Unit (CMRU), UT Southwestern
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utsouthwestern.edu ↗ - Associate Program Director
Internal Medicine Residency Research, UT Southwestern
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →labs.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sessions.hub.heart.org ↗
Secondary affiliations
appointments beyond the home institution- Secondary appointment
Division of Geriatric Medicine, UT Southwestern
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →labs.utsouthwestern.edu ↗
- Adjunct Faculty
Institute for Exercise and Environmental Medicine (IEEM), Texas Health Resources
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texashealth.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffecardiology.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Madhukar Trivedi, MD
UT Southwestern Medical Center
Ildiko Lingvay, MD
UT Southwestern Medical Center
Anthony Bavry, MD
UT Southwestern Medical Center
Philip Raskin, MD
UT Southwestern Medical Center